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Highlights: 
1. GEANT4 accurately simulates percentage depth dose generated by uniform monochromatic 
X-ray beams in the keV energy range. 
2. Simulations highlight a dose enhancement when contrast agents are irradiated with photons 
with energies above the K-edge.
3. Dose enhancement factors depend on incoming photon energy and high-Z compound’s 
concentration. 
4. Dose enhancement factors calculated with GEANT4 for iodine and gadolinium are in 
agreement with experimental values.
Abstract 
The local dose deposition obtained in X-ray radiotherapy can be increased by the presence of 
metal-based compounds in the irradiated tissues; this finding is strongly enhanced if the 
radiation energy is chosen in the kiloelectronvolt energy range, due to the proximity to the 
absorption edge. Monte Carlo (MC) calculations facilitate the estimation of this effect by 
predicting the dose distribution in a specific phantom. In this study, we present a MC 
application developed with the toolkit GEANT4 to investigate the dosimetric distribution of a 
uniform monochromatic X-ray beam, and benchmark it against experimental measurements. 
Two validation studies were performed, using a commercial PTW RW3 water-equivalent slab 
phantom for radiotherapy, and a custom-made PMMA phantom conceived to assess the 
influence of high atomic number compounds on the dose profile, such as iodine and gadolinium 
at different concentrations. Good agreement was found for the monochromatic energies 
considered, which were in the range of 30-140 keV. A dose enhancement was observed in the 
calculations, corresponding to the regions containing the contrast agents. Dose enhancement 
factors (DEFs) were calculated, and  the highest values were found for energies higher than the 
corresponding K-edges of iodine and gadolinium. The in-silico results are in line with the 
empirical findings, which suggest that GEANT4 can be satisfactorily used as a tool for the 
calculation of the percentage depth dose (PDD) at low energies in the presence of contrast 
agents. 
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1. Introduction 
Radiation therapy (RT) is one of the most common and efficient treatments of cancer, and it 
makes use of ionising radiation to cause lethal damage to the tumoral cells by damaging the 
cellular DNA. The efficacy of RT can be increased if the tumour is previously loaded with high 
atomic number (Z) compounds and then irradiated with X-rays in the kiloelectronvolt energy 
range. In this case, the local dose deposition is enhanced because the effective Z of the tumour 
is increased compared to the adjacent tissues. X-rays are preferentially stopped by high-Z 
elements due to the larger photoelectric cross section (∝ Z4) compared to tissue/water, with the 
emission of electrons, which contribute to the local dose deposition in the vicinity of the high-
Z atoms. K-shell vacancies created during the absorption process are filled with higher orbital 
electrons, leading to the generation of either Auger electrons, which have a short mean free 
path and are deposited locally, or fluorescent X-rays, which escape from the original target 
zone. This produces a confined dose enhancement in the tumour volume without damaging the 
surrounding tissues [1,2], with a consequent increase of the probability of tumour control [3-
5]. Two natural candidates as dose enhancers are iodine and gadolinium, which are both high-
Z, biologically-compatible elements, already used in diagnostic imaging. Iodinated (Z=53) and 
gadolinium-based (Z=64) contrast media are used in computed tomography and magnetic 
resonance imaging respectively, with the aim to enhance the image contrast between highly 
vascularized and neighbouring tissues.  
A particular case is encountered when the high-Z material is associated to a chemotherapic 
drug. Such drugs become photoactivable when irradiated with monochromatic X-rays at 
energies just above the K-edge of the metal, which for most elements occurs at energies <100 
keV. For this to happen in practice, X-ray beams of the suitable energy and with a sufficiently 
high fluence, such as the ones available at synchrotron radiation facilities, have to be used. 
When tissues are irradiated with conventional radiotherapy units (mean photon energies > 
1MeV) the photoactivation would only marginally contribute to the local dose deposition, 
because the Compton scattering would replace the photoelectric effect as main X-ray 
interaction depositing dose. This was confirmed by a study from Zhang et al., where an almost 
negligible dose enhancement by gadolinium was found when using megavoltage external 
beams involved in clinical radiotherapy [6]. 4 and 6 MeV Linac beams filtered with low-Z 
targets such as beryllium and aluminium were considered by Robar in order to produce an 
energy spectrum more suitable for contrast enhanced radiation therapy. They found an increase 
in the relative population of photons in the vicinity of the K-edge of iodine, although the 
magnitude of dose enhancement cannot be expected to reach that for kilovoltage x-ray beams 
[7]. 
Intense, highly monochromatic X-ray beams at energies up to 100 keV are available at the 
ID17 biomedical beamline of the European Synchrotron Radiation Facility (ESRF) in 
Grenoble, where different photoactivation protocols have been studied; additionally, some 
molecular and cellular mechanisms involved in metal-based chemotherapy plus synchrotron 
radiation (SR) have been identified [8-13]. In all protocols, the critical point is the possibility 
of loading biocompatible high-Z drugs at a sufficiently high concentrations for determining a 
significant increase of the local dose deposition into the tissues.  
Monte Carlo (MC) simulations are the method of preference to predict the dose distribution 
determined by the presence of metals. Back in 1992, Solberg et al. [14] developed a Monte 
Carlo application based on the MCNP4 code to calculate the radiation dose enhancement 
factors (DEF) in the therapy of brain tumours using iodinated contrast agents. They studied the 
factors that influence the DEFs and suggested that higher DEFs can be achieved using 
monochromatic beams with energies near the K-edge of iodine or gadolinium. Verhaegen et 
al. [15] investigated with the BEAMnrc MC code the influence of different kiloelectronvolt 
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spectra when used with a range of clinically achievable gadolinium and iodine concentrations. 
The experimental validation of their calculations was performed using a polychromatic X-ray 
beam at 120 kVp irradiating contrast media solutions placed between two PMMA slabs and 
measuring the dose at different depths using unlaminated radiochromic films [16]. In terms of 
beam size, a Monte Carlo study conducted with the PENELOPE code reported gadolinium as a 
very suitable dose enhancer in microbeam radiation therapy applied to brain tumours [17].  
In this work, we analysed the suitability of GEANT4 for depth dose studies using a 
homogeneous X-ray monochromatic beam in the kiloelectronvolt energy range. We also 
investigated on the GEANT4 performances in dose enhancement simulations when using 
clinically accepted contrast agents (iodine and gadolinium) at different concentrations. We 
considered the depth dose reduction in the regions adjacent to the contrast agent regions, and 
compared the simulated results with experimental measurements collected at the biomedical 
beamline ID17 of the ESRF. The final goal is to have a benchmarked application to be used in 
future depth dose studies at low energies in the presence of contrast agents, which will be then 
extended to the use of polychromatic radiation and micrometer-sized beams. 
2. Materials and Methods 
2.1 GEANT4 simulation setup 
GEANT4 is a Monte Carlo toolkit widely used in dose calculations thanks to the well-validated 
physics models, powerful geometry modelling tools, and convenient visualization utilities. We 
used version 10.4, which includes an updated database for electromagnetic low energy physics. 
In particular, we used the G4EmStandardPhysics_option4 electromagnetic physics libraries 
that contains a selection of the most accurate standard and low energy models available in 
GEANT4; they are therefore recommended for medical applications [18]. The General Particle 
Source (GPS) class allowed the definition of the source energy, position and size. To calculate 
the PDD in the phantom we used monochromatic energies in the range 30–140 keV; the X-ray 
beam was simulated as a homogeneous planar source of 2x2 cm2 impinging perpendicularly 
on the phantom. A total of 109 incident photons were simulated. The range cut was set to 1 µm, 
with a low energy limit for secondary particles production of 250 eV. GEANT4 contains a 
command-based, built-in scoring mesh that allows the user to divide the phantom in a three-
dimensional array of voxels, and score commonly used physics quantities such as the absorbed 
dose. We used a voxel resolution of 10 x 10 x 5 mm3 in the first part of the study, and 10 x 10 
x 1 mm3 in the dose enhancement analysis. The phantoms simulated have the same shape, 
dimensions and materials of those used in our experiments, which are represented in Fig. 1A 
and Fig. 1B and will be described in the following paragraphs. The metal-based compounds 
have been simulated at different concentrations, defining the compound density and the 
fractional mass of each component. Values have been chosen in agreement with the effective 
measured mass concentrations as described in 2.3. 
2.2 The ID17 beamline and the beam harmonics content estimation 
The experiments were performed at the ID17 biomedical beamline of the ESRF. The beamline 
originates from a wiggler source (10 full periods; period length: 150 mm). The generated X-
ray beam is filtered by permanent absorbers (Be: 2.0 mm; C: 0.5 mm; Al: 0.5 mm) before 
reaching the double Si(111) bent Laue crystal monochromator [19] which allows to select a 
working energy in the interval 25-140 keV. The beam can be shaped using three different sets 
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of remotely controlled tungsten slits, which also allow to efficiently remove the scattered beam. 
The sample was positioned on a remotely controlled platform placed in the experimental hall 
(starting at about 145 m from the source), which allows positioning and scanning the sample 
through the beam with micrometric precision. The X-ray beam is transported in ultra-high 
vacuum until the last Kapton window, located ~ 8 m upstream from the sample. In the case of 
the Si(111) reflection, also third- and eventually fourth-order harmonics might contaminate the 
beam diffracted by the crystal monochromator; second-order harmonics are, in fact, not 
allowed by the selection rules for the silicon crystal structure [19]. For the irradiations at 30 
and 35 keV, a wiggler gap of 60 mm was used, corresponding to a maximum field of 0.61 T, 
while, for 40 keV, the gap was set to 56 mm, corresponding to a magnetic field of 0.68 T. By 
using the XOP software [20] we calculated the flux at the fundamental energy (30 keV, 35 
keV, 40 keV) and the third- and fourth-order harmonics (respectively 90 keV and 120 keV; 
105 keV and 140 keV; 120 keV and 160 keV) delivered by the source. The photon fluxes were 
then transported through the permanent absorbers and the 8 m of air using the NIST databases 
[21]. Finally, the values were scaled by the reflectivity curve size of the crystal at the different 
energies. The reflectivity power for the third- and the fourth-order harmonics were estimated 
in 3 and 4, respectively [19]. The so calculated values of third and fourth harmonic 
contaminations of the X-ray beam delivered by the monochromator were used as inputs for the 
Monte Carlo calculations reported in 2.3. 
2.3 Benchmarking of the GEANT4 simulations with solid water phantom dosimetry 
In our experiment, we measured the depth dose profiles deposited by monochromatic X-ray 
energies ranging from 30 to 140 keV, and compared with the calculated dose profiles. We 
employed a PTW RW3 water-equivalent slab phantom with dimensions of 30 x 30 x 12 cm3
(Fig. 1A). The phantom contained a plate with a recess to hold an ionisation chamber. Solid 
water phantoms are often used as water substitute in dosimetry calibration, quality assurance, 
and patient‐specific output measurement [22,23]. For real-time dosimetry measurements, we 
used a PTW 31010 semiflex ionisation chamber, which has a sensitive volume of 0.125 cm3. 
We could recombine the slabs (typically 0.5-1 cm thick) in order to move the ionisation 
chamber and evaluate the dose deposited at different depths. A second set of experimental data 
was collected using EBT3 GafchromicTM films [24]. The dynamic range of this type of film is 
0.2-20 Gy, making it suitable for many medical applications. Unlike an ionisation chamber, 
the Gafchromic film does not give a real-time dose measurement, as it contains colourless dyes 
that become blue after X-ray exposure due to radiation-induced polymerisation; this chemical 
conversion requires about 24 hours for its full development. For an accurate film dosimetry, 
three sets of calibration films were irradiated at three different energies (30, 50 and 100 keV), 
delivering a dose of 0, 0.5, 1.0, 2.0, 5.0, 10.0 and 15.0 Gy for each energy. Based on these 
curves we established the calibration curves (not shown) which permitted to estimate the 
unknown doses in the irradiated films. After irradiation, the film was scanned with an EPSON 
V750 scanner and the optical density was determined with MATLAB. The entrance dose 
delivered experimentally was 2.0 Gy for measurements using the PTW chamber and 10.0 Gy 
with the EBT3 film. 
2.4 Experimental dosimetry with dose enhancers 
We examined the contribution of iodine (10 mg/ml) and gadolinium (4 mg/ml) to the PDD 
within the sample. The compositions have been measured by an agreed laboratory (FILAB); 
the simulations have been performed based on the effective measured mass concentrations.
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Our custom-made phantom had a size of 50 x 50 x 88 mm3 (Fig. 1B), and was made of three 
PMMA blocks interspersed with two containers (each 14 mm thick) filled with the dose 
enhancers. One of the three blocks of PMMA had a cavity allowing the insertion of a PTW 
31010 semiflex chamber, so we could take measurements at different depths. The experimental 
energies were determined considering the K-edge binding energy of the two metals used, which 
are 33.17 keV for iodine and 50.24 keV for gadolinium. We employed monochromatic energies 
of 30 keV, 35 keV, 45 keV, 55 keV and 75 keV. The nominal entrance dose delivered was 5 
Gy. Before each set of measurements (i.e. for each monochromatic energy used), we irradiated 
the block containing the ionization chamber on its own to verify the accuracy of the entrance 
dose; for this purpose we used the protocol described in Prezado et al. [25]. Due to limitations 
in the dose measurement devices at our disposal (thickness of the ionisation chamber), we 
could not acquire multiple empirical data at different depths inside the high-Z solution. 
2.5 Determination of uncertainties 
The uncertainty in the ionisation chamber measurements has been assumed to be ±5% for 
energies up to 75 keV and ±2% for higher energies; these are the maximum errors reported in 
the ionisation chamber specifications combined with the uncertainty of the chamber 
calibration. To reduce the chamber statistical error during the experiment, we repeated each 
measurement three times and considered the mean value obtained. The statistical uncertainty 
in the film measurements has been calculated following the methodology developed by Devic 
et al [26]. The film was calibrated such that the optical density was fitted as a function of dose 
to the film, using the form 
nDose a netOD b netOD    (1) 
where a, b and n are determined using a least square fit. The sigma uncertainties on a, b and n
were then considered by taking the square root of the diagonal values of the covariance matrix 
from the fit. The percentage uncertainty on the dose measurement may then be calculated by 
using the following formula: 
2 2 2 2 1 2( )
(%) 100
n n
a b n
D
netOD netOD a n b netOD netOD
D
  

        
    (2) 
3. Results 
3.1 Calculation of the harmonics 
The calculated third- and fourth-order harmonic contents at the entrance of the phantom are 
reported in Table 1. The values were derived following the procedure described in section 2.2. 
These values have been used as inputs of the Monte Carlo simulations of 3.2 to fully describe 
the beam characteristics entering the sample. 
3.2 Validation of the GEANT4 simulations against experimental measurements 
In Fig. 2, we report the comparison of the simulated PDDs with the experimental 
measurements. The doses were normalised to 1 at 5 mm in depth along the z axis for an easier 
evaluation of the differences between the curves; 5 mm corresponds to the depth at which we 
placed the ionisation chamber, and hence the first available measurement. Solid lines show the 
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simulated PDD, and therefore the percentage of dose found at different depths compared to the 
one delivered at 5 mm in depth; the red circles represent the PTW semiflex ionisation chamber 
measurements, while the blue triangles correspond to the film data. To better highlight the 
differences with the simulations, the bottom panels in Fig. 2 show the percentage difference 
ratios calculated as: 
4 exp
exp
( ) ( )
% 100
( )
GEANTDose d Dose dDifference
Dose d

  (3) 
where Dose(d)GEANT4 is the dose calculated at a specific depth with GEANT4, and Dose(d)exp is 
the dose at a specific depth measured with the PTW semiflex chamber or the EBT3 films. The 
experimental measurements are used as the reference term in both cases. In the bottom panels, 
the red circles correspond to the percentage difference between the ionisation chamber and the 
calculations, while the blue triangles give the differences between the film measurements and 
the simulations.  
As expected, all the simulated dose profiles show a progressive attenuation with depth. For a 
given depth, the attenuation is less pronounced at higher energies (e.g., at 30 keV the dose at 
100 mm is about 2-3% of the dose at 0.5 mm, while at 140 keV the dose is 26% at the same 
depth). The absolute doses obtained empirically show a comparable fall off, with maximum 
percentage difference obtained at 30 keV (about 5% at 10 cm depth) and 35 keV (about 6% at 
6 cm depth) (Tab. 2). Overall, the dose measured with the chamber tends to be higher than the 
one measured with films. The agreement between simulations and experimental data is good 
overall, but the error diagrams reveal a tendency for GEANT4 to predict a more pronounced 
dose fall off than measured empirically at low energies at larger depths (30 mm or more at 30 
keV, 60 mm or more at 35 keV), and a less pronounced fall off at higher energies. Before 
considering the contribution of high-order harmonics to the beam’s energy compared to the 
monochromatic energy used in the simulations, there is was a disagreement at the lowest 
energies that reaches reached 32% at 30 keV and 19% at 35 keV. From 80 keV the tendency 
is opposite, and the calculated dose deposition is slightly lower than the measured one. In 
general, tThe agreement considerably improved with the inclusion the harmonics contribution, 
stays staying within 8% for all the energies examined. 
3.3 The influence of high-Z materials on the PDD 
For this part of the validation study we used the phantom shown in Fig. 1B. Our objective was 
to study the effect high-Z materials on dose deposition at different depths. The experimental 
measurements were carried out by filling the phantom with a water solution containing 10 
mg/ml iodine or 4 mg/ml gadolinium. The same setup was simulated with GEANT4.  
The resulting depth dose deposition profiles are reported in Fig. 3 for iodine and Fig. 4 for 
gadolinium. The solid lines represent the simulated results, with different colours denoting 
different energies. The points correspond to experimental measurements, with the same colour 
notation for different energies. For all five energy levels, experimental measurements were 
taken using the chamber at depths of 5, 39 and 73 mm, respectively. As before, both sets of 
measurements are normalised to the dose at 5 mm depth.  
For all energies, the simulated data show both an underlying decreasing trend representing the 
reduction of the deposited dose as the beam travels through the phantom, and two spikes 
corresponding to when the beam travels through the containers filled with the high-Z solution. 
The experimental measurements confirm the predicted dose decrement giving a good match of 
the dose deposited in PMMA. In Fig. 3, at 30 keV, just below the iodine K-edge energy, the 
increase in dose deposition as the beam enters the solution is about 75% compared to PMMA. 
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Above the iodine K-edge, i.e. at 35 keV, the increase is about 150%. The higher dose 
enhancement is seen at 45 keV in the first solution container, where the increase is about 190%, 
and at 55 keV at a depth of 54 mm, which corresponds to the second container, where we can 
still see an increase of 80%. At 75 keV we still observe an increase of 100% in the first 
container and 55% in the second. In the case of gadolinium (Fig. 4), the dose enhancement 
observed is much lower because the concentration used is less than half of the iodine one, so 
we used a shorter vertical axe to better evaluate the differences. Similarly to iodine, the 
maximum dose enhancement for gadolinium is seen at 55 keV, in the first container, and 55-
75 keV in the second one, which is above the gadolinium K-edge energy. If we increase the 
gadolinium concentration from 4 mg/l to 10 mg/ml (Fig. 5), the total dose enhancement 
increases (the vertical axe is now comparable with that of iodine in Fig. 3), the monochromatic 
energy of 55 keV still gives the highest dose enhancement; however, this time the 75 keV beam 
is predominant in giving the highest dose enhancement in the second container. In general, for 
the same concentration of 10 mg/ml we can observe a higher dose enhancement in iodine than 
gadolinium, with differences of 40% at 21 mm, and 20% at 54 mm. 
3.4 Dose enhancement factor 
The DEF is computed as the ratio between the dose recorded when the two containers are filled 
with the high-Z solution and the dose recorded when they are filled with water. It is a useful 
metric to determine a scale of dose enhancement resulting from the use of the high-Z elements. 
Using our simulations, we can compute DEFs at energies of 30, 35, 45, 55 and 75 keV for both 
iodine and gadolinium at a concentration of 10 mg/ml. The experimental data allow us to assess 
the corresponding DEFs outside the containers at depths of 5, 39 and 73 mm only for iodine, 
as the gadolinium concentration used experimentally was much lower. 
The decrease in DEF at larger depths, observed after the beam goes through the containers, 
represents the additional dose attenuation resulting from the larger number of interactions of 
the primary photons and especially secondary particles taking place inside each container when 
this is filled with a high-Z contrast medium. The results for iodine 10 mg/ml are reported in 
Fig. 6; the experimental measurements show that the GEANT4 code predicts that attenuation 
accurately. At energies just above the iodine K-edge, the fall-off after the beam enters the 
solution is very steep, while it becomes less prominent as the energy increases. With respect to 
dose enhancement, the effect is not monotonically increasing in energy. In both containers, the 
largest effects are found at 55 keV, followed by 45, 75, 35 and 30 keV. The simulated DEFs 
for gadolinium at a concentration of 10 mg/ml are reported in Fig. 7. We can see that the fall-
off when the beam goes through the solution is smoother than the one of iodine, with maximum 
DEFs reached for 55-75 keV in the first container and 75 keV in the second. The DEFs obtained 
inside the gadolinium compound are 20% lower than the ones achieved when using iodine. 
We calculated the DEFs also for different iodine concentrations, i.e. 5, 10 and 20 mg/ml, at 45 
keV (Fig. 8A) and 55 keV (Fig. 8B), where the maximum depth dose deposition has been 
previously found. The DEFs profiles at different concentrations show a similar trend. A spike 
can be noticed as the beam enters the solution (at about 20 and 54 mm depth, respectively), 
followed by a gradient of dose fall-off as the radiation travels inside the solution. Higher 
concentrations give a maximum DEF and show a steeper fall-off gradient due to the beam 
attenuation. The 45 keV beam produces steeper spikes and lower DEFs compared to the 55 
keV beam, with differences up to 40% in the second container at a depth of 54 mm. 
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Discussion 
The use of high-Z compounds has gained increasing interest in radiotherapy due to the 
observed dose enhancement after photon irradiation. This effect is particularly evident when 
using beams in the kiloelectronvolt energy range as photons have energy closer to the K-shell 
binding energy of the high-Z materials. At such energies, photons interact mainly via 
photoelectric absorption and Compton scattering, both leading to the production of secondary 
electrons, which contribute, therefore, to the local dose deposition in the vicinity of the high-Z 
compound. In water, photoelectric absorption is prevalent at very low energies, while above 
about 30 keV Compton scattering becomes dominant [21]. At the energy range considered, 
secondary electrons travel for 0.01-1 mm in water, so they will deposit their energy locally. As 
a consequence, the shape of the depth dose curve depends largely on the attenuation of primary 
photons and the dose deposition of scattered photons. 
In this work we explored the suitability of GEANT4 to be used as a Monte Carlo toolkit for dose 
enhancement studies when using synchrotron generated uniform monochromatic beams. We 
compared the theoretical results with experimental measurements acquired via a PTW semiflex 
ionisation chamber and EBT3 GafchromicTM film. The experimental absolute doses 
(considered before the normalisation) stayed within the statistical uncertainty at all energies. 
When using the RW3 commercial slab phantom, the simulated depth dose curves compared 
well with the experimental measurements apart from lower energies. We found that this was 
due to the presence of high-order harmonics, making up a non-trivial component to the beam 
energy compared to the monochromatic energy used in the simulations. We quantified the 
harmonics’ contribution and found the highest contamination at 30 keV, i.e. up to 2.5% of the 
fundamental energy at the entrance of the sample. The harmonics’ contribution on the incoming 
beam decreases with energy, being up to 0.98% at 40 keV. Considering how the percentage 
differences are calculated, it is worth highlighting that the differences look larger at lower 
energies because we are dividing for a smaller number, being the dose at 10 mm lower for 30 
keV than for higher energies. The same behaviour is in fact observed considering the measured 
absolute doses (film compared to ionisation chamber), where the highest discrepancies of up 
to 6% are also found at the lowest energies of 30 keV and 35 keV. The ionisation chamber 
differences are inside the uncertainty region for most of the energies, while the best agreement 
with the film is found at 45-50 keV.  
After filling the phantom with the high-Z compound, as expected, the depth dose curves did 
not show a simple decreasing trend following the Beer-Lambert law. A dose enhancement was 
found inside the metal-based mixtures for all studied energies. The dose was not measured 
experimentally inside the liquid due to the lack of a commercial dosimeter of appropriate 
thickness to produce meaningful results. In fact, the same high-Z effect that justifies the high 
specificity of the dose distribution (short distance travelled by the photoelectrons, characteristic 
X-rays and Auger electrons) also makes the dose enhancement generated by these agents 
difficult to measure. The laminated radiochromic films have in fact a polyester layer that, 
although very thin (i.e. 125 m for EBT3 films) would stop the secondary electron generated, 
giving a lower detected dose deposition. On the other hand, the use of unlaminated films, such 
as the HD-V2, is unmanageable as the active layer would dissolve into the solution. 
Calculating the depth dose curves was the first essential step in order to determine the DEF, 
which is defined as the ratio between the dose to water with enhancers and the dose to water 
alone. For iodine 10 mg/ml, the simulations showed the highest dose enhancement at 45 keV 
when the beam enters the solution in the first container, and at 55 keV in the second. The 
highest DEF was found at 55 keV, followed by 45 keV. These results look interesting 
considering that the iodine K-edge corresponds to an energy of 33.17 keV. An explanation of 
this fact can be found by looking at the mass energy absorption coefficient in water and iodine, 
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which involves the absorption not only of the primary photon, but also of the secondary 
particles produced by the primary photon when travelling through the medium. Roeske et al. 
[27] showed that the DEF is directly proportional to the ratio of the mass energy absorption 
coefficient in the dose enhancer with a given concentration and the same coefficient in water; 
this occurs when a monochromatic photon beam is used, the density in the irradiated medium 
is uniform, and under conditions of charged particle equilibrium. At the energies considered in 
this study, this ratio has a maximum at about 50 keV [21], which is in line with our results. By 
considering different iodine concentrations, we found higher DEFs at higher concentrations, 
due to an increased number of secondary interactions in iodine compared to water, while the 
calculated dose deposition in PMMA has the opposite trend (it decreases as the concentration 
increases). As far as the gadolinium is concerned, the highest dose enhancement was seen at 
55 keV in the first container and 75 keV in second one. The highest DEFs were also found at 
55 keV and 75 keV. This is in line with what found for iodine, if we consider that the 
gadolinium K-edge energy is higher and equal to 50.2 keV. In general, for equal concentrations, 
we found higher DEFs in iodine than gadolinium. 
Conclusion 
This study investigated the use of GEANT4 as a Monte Carlo simulation tool to predict the dose 
distributions at low energies when using a uniform monochromatic synchrotron-generated X-
ray beam in different experimental configurations. The final goal was to assess via simulations 
the potential dose enhancement given by the introduction of high-Z compounds in a phantom 
irradiated with targeted keV radiation, with some measurements to enable a comparison with 
the model. We considered the PDD obtained with the irradiation of a commercial PTW RW3 
phantom, and benchmarked the results against experimental measurements acquired at the 
ESRF with two different dosimeters such as a PTW semiflex chamber and EBT3 
GafchromicTM films. The contribution of high-order harmonics to the incoming beam was 
quantitatively assessed for the monochromatic energies in the range 30-40 keV, and an 
agreement within 8% was found among simulations and empirical data for all the 
monochromatic energies considered. At low energies,, the highest discrepancy (within 6%) 
was found between the absolute dose measured with the ionisation chamber and the one 
measured with films at higher depths (6-10 cm), highlighting the difficulty in dealing with such 
small doses. 
We considered the effect of the introduction of high-Z regions in a PMMA phantom, by filling 
two containers with iodinated and gadolinium-based compounds, for different concentrations 
and incident X-ray energies. The calculations clearly emphasised a dose enhancement in the 
contrast medium areas, and the experimental measurements carried out in PMMA just before 
or after those regions overlapped the depth dose deposition simulated with GEANT4. The dose 
enhancement factors were used to evaluate the increase of the dose in the phantom. Results of 
this study indicate that DEFs are both photon energy- and concentration- dependent, and the 
highest DEFs are found for energies not immediately above the K-edge, but slightly higher. 
According to the results, a rapid increase in the DEF values is obtained with increased 
concentrations. The results of this work support the use of GEANT4 as a tool for the calculation 
of the PDD at low energies in the presence of contrast agents. 
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Fig. 1. Phantoms used experimentally. 
A: photo of the PTW RW3 water-equivalent slab phantom at the ESRF with PTW chamber 
inserted. B: Schematic diagram of the phantom used to measure the difference in dose 
deposition with the contrast agent. The two containers A and B, placed in between the PMMA 
blocks, were filled with the metal-based compounds. One of the PMMA blocks had a cavity to 
allow the insertion of a PTW 31010 semiflex chamber. The blocks and containers were 
detached and could be positioned in different sequences in order to reproduce different 
geometries. 
Energy of the 
fundamental (keV) 
Third-order 
harmonic 
content (in %)
Fourth-order 
harmonic content 
(in %)
30 2.2 0.3
35 1.1 0.1
40 0.9 0.08
Tab. 1 Harmonic content in percentage at the entrance of the phantom. In the experiment, for 
energies of the fundamental above 40 keV, the harmonic content is negligible (<0.3 %) 
Energy/ 
Depth 
(mm) 30 keV 35 keV 40 keV 45 keV 50 keV 80 keV 120 keV 140 keV
10 0.6 -0.3 1.5 -0.1 2.1 -0.2 0.1 -0.2
20 1.6 0.02 2.0 1.0 2.1 0.3 0.2 0.9
30 1.7 3.4 4.2 3.9 4.3 2.2 2.5 2.2
40 0.5 5.6 5.4 4.3 3.8 2.8 2.9 3.1
60 -0.8 6.1 5.3 6.1 5.2 3.8 1.8 3.2
100 -4.7 -1.3 1.4 3.8 4.3 4.0 0.9 1.3
Tab. 2 Percentage differences in experimental dose measurements acquired at different 
energies with EBT3 and semiflex chamber. The film measures are considered as reference 
term. 
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Fig. 2. Top: The normalised experimental percentage depth dose acquired at different energies 
with the PTW semiflex ionisation chamber (red circles) and the EBT3 GafchromicTM films 
(blue triangles) are compared with Monte Carlo simulations (solid lines). The experimental 
measurements are used as reference term in both cases. Bottom: percentage differences 
between data acquired with ionisation chamber and calculations (red circles), percentage 
differences between film measurements and calculations (blue triangles), and experimental 
uncertainties corresponding to the ionisation chamber (red dashed lines) and film 
measurements (blue dashed lines). 
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Fig. 3. Dose deposition at different energies when filling the phantom with iodine solution at 
10 mg/ml. The solid lines represent the simulated results. The points correspond to 
experimental measurements. Different colours denote different energies. All sets of 
measurements are normalised to the dose at 5 mm in depth. 
Fig. 4. Dose deposition at different energies when filling the phantom with gadolinium solution 
at 4 mg/ml. The solid lines represent the simulated results. The points correspond to 
experimental measurements. Different colours denote different energies. All sets of 
measurements are normalised to the dose at 5 mm in depth. 
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Fig. 5. Dose deposition at different energies when filling the phantom with gadolinium solution 
at 10 mg/ml.  
Fig. 6. Dose enhancement factors calculated with GEANT4 (solid lines) and benchmarked 
experimentally in PMMA (points) using a iodine solution 10 mg/ml as dose enhancer. Different 
colours denote different energies. 
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Fig. 7. Dose enhancement factors calculated with GEANT4 in a gadolinium solution at 10 
mg/ml.  
Fig. 8. Dose enhancement factors calculated with GEANT4 at 45 (A) and 55 keV (B) using 
different iodine concentrations. 
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